Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Articles Tagged "resorbable materials"

Orthopaedic Product Development: Forecasting Changes to Come

by BONEZONE | Nov 2018

Considering surgical techniques, regulations and technologies together as a whole, expect to see significant changes in orthopaedics over the next decade. Here we present seven shifts that OEMs should consider when choosing new product development initiatives.... Read more »

Synthetic Bioresorbables: Orthopaedics’ Evolution from PLLA to New Formulas

by BONEZONE | Nov 2018

These polymers have broad orthopaedic application. This article presents a focus on the transition away from Poly-L-lactic acid (PLLA)-type resorbable polymers to updated and novel resorbable biomaterials that are designed to perform better clinically.... Read more »

206 Ortho Secures Patent for Technology That Incorporates Biodegradable Material

by BONEZONE | Jul 2018

The company has developed a bio-inspired non-metallic composite and implants made with a high-strength, biodegradable material intended to repair load-bearing bone and resorb completely. 206 Ortho is pursuing additional funding and potential commercialization partners.... Read more »

DSM Announces New Braiding Technology for Dyneema Purity Fiber

by BONEZONE | Nov 2017

  It has specific applications in sports medicine and other orthopaedic and spinal procedures.... Read more »

DSM Introduces Dyneema Purity Black Fiber

by BONEZONE | Mar 2017

The product addresses an unmet need for strongly-contrasting material for complex suture procedures.  ... Read more »

Proxy Biomedical Announces Facility Expansion

by BONEZONE | Dec 2015

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »

Purac Acquires Fiberlive Technology from Vivoxid

by BONEZONE | Oct 2012

Adaptive designs have emerged as an attractive alternative to traditional clinical studies due to the potential to reduce resources, time and costs. However, several critical components must be considered to determine whether such a trial design is a fit for you.... Read more »